Through its many partnerships with nonprofits that have similar missions, the Foundation participates in advocacy initiatives that benefit people living with cutaneous lymphoma. The following are just some of our Advocacy partners:
The mission of the CSD is to advocate on behalf of individuals with skin disease through
The CSD also works closely with the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to coordinate research efforts for all skin diseases. Members of the Coalition meet annually with members of Congress and testify when selected before the appropriations committees to educate Congress and the public on the seriousness of skin diseases while stressing the need for increased medical funding.
For more information, visit www.coalitionofskindiseases.org
The Lymphoma Coalition is a global network of worldwide not for profit lymphoma patient organizations with a vision to free the world of lymphomas. The coalition is made up of 56 member organizations from 40 countries. It began in 2002 with 4 countries sharing best practices and now work together in many advocacy initiatives and educational dissemination and support.
The Lymphoma Coalition's Mission is:
For more information, visit www.lymphomacoalition.org
The Lymphoma Research Foundation (LRF) established the Lymphoma Education and Advocacy Partners (LEAP) in an effort to coalesce the community around those policy issues which have the greatest impact on the lymphoma community. They focus on those issues of highest priority to people with lymphoma, including access to quality cancer care, treatment cost, investment in innovation and lymphoma clinical trials.
LEAP's fundamental goal is to bring together patient advocacy organizations with similar missions to educate and advocate on behalf of the lymphoma community. They believe that through the collective voice of patients, survivors, caregivers and medical professionals, that legislation and policies can be developed so as to positively impact the lives of Americans living with a lymphoma diagnosis.
LRF is excited to be joined by our founding member organizations: the Cutaneous Lymphoma Foundation (CLF), the International Waldenstrom's Macroglobulinemia Foundation (IWMF), the T-cell Leukemia Lymphoma Foundation (TCLLF) and The Double Hit Lymphoma Foundation (TDHLF). We believe that working together to educate members of the lymphoma community on policies that affect their lives and assist them to engage with the individuals who develop these policies that we can really make a difference in the lives of those touched by a lymphoma diagnosis.
For more information, visit www.lymphoma.org
One Voice Against Cancer is a collaboration of national non-profit organizations representing millions of Americans, who deliver a unified message to Congress and the White House on the need for increased cancer-related appropriations. Created in 2000, it has grown into an effectiver lobbying coalition on cancer funding that has enabled the community to enhance policymaker's awareness of the need for substantial increases in essential cancer programs.
OVAC hosts an annual Lobby Day providing volunteers an opportunity to meet with House and Senate members on the Hill.
For more information, visit www.ovaconline.org
REAP is an umbrella coalition comprised of 61 patient advocacy groups whose mission is to communicate the challenges patients face in accessing care to Federal and State policymakers. REAP’s collective voice assures a wide range of patient concerns are considered in policy development to maximize care access and improved outcomes as well as minimize unintended consequences upon implementation. REAP, through its member entities, contributes information and perspectives regarding important health care decisions to a degree that has not been possible heretofore by health care advocacy groups in the regulatory arena.
For more information, visit www.reapforum.org
This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.